Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 16 01 2019
accepted: 27 05 2019
entrez: 9 7 2019
pubmed: 10 7 2019
medline: 19 2 2020
Statut: epublish

Résumé

Late onset Alzheimer's disease is the most common form of dementia for which about 30 susceptibility loci have been reported. The aim of the current study is to identify novel genes associated with Alzheimer's disease using the largest up-to-date reference single nucleotide polymorphism (SNP) panel, the most accurate imputation software and a novel gene-based analysis approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 million genotypes from 17,008 Alzheimer's cases and 37,154 controls. In addition to earlier reported genes, we detected three novel gene-wide significant loci PPARGC1A (p = 2.2 × 10-6), RORA (p = 7.4 × 10-7) and ZNF423 (p = 2.1 × 10-6). PPARGC1A and RORA are involved in circadian rhythm; circadian disturbances are one of the earliest symptoms of Alzheimer's disease. PPARGC1A is additionally linked to energy metabolism and the generation of amyloid beta plaques. RORA is involved in a variety of functions apart from circadian rhythm, such as cholesterol metabolism and inflammation. The ZNF423 gene resides in an Alzheimer's disease-specific protein network and is likely involved with centrosomes and DNA damage repair.

Identifiants

pubmed: 31283791
doi: 10.1371/journal.pone.0218111
pii: PONE-D-19-01465
pmc: PMC6613773
doi:

Substances chimiques

Amyloid beta-Peptides 0
Nuclear Receptor Subfamily 1, Group F, Member 1 0
PPARGC1A protein, human 0
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha 0
Proteins 0
RORA protein, human 0
ornithine decarboxylase antizyme 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0218111

Subventions

Organisme : Medical Research Council
ID : MC_PC_17112
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U123160651
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U24 AG021886
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00024/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U24 AG056270
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00024/8
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1100540
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600237
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J004758/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U01 AG052409
Pays : United States
Organisme : Medical Research Council
ID : G0901254
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U01 AG049505
Pays : United States
Organisme : Medical Research Council
ID : MR/K01417X/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS017950
Pays : United States
Organisme : Medical Research Council
ID : G0902227
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG054076
Pays : United States
Organisme : Medical Research Council
ID : MR/L023784/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001253
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U01 AG032984
Pays : United States
Organisme : Medical Research Council
ID : MR/L501542/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009076/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1604/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1307
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013041/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0300429
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0900652
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400074
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : P30 AG010129
Pays : United States
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701075
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L501517/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0502157
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Acta Neuropathol Commun. 2014 Dec 10;2:170
pubmed: 25492529
Nature. 2007 Jun 14;447(7146):799-816
pubmed: 17571346
Prog Neurobiol. 2012 May;97(2):142-51
pubmed: 22100502
PLoS One. 2010 Nov 15;5(11):e13950
pubmed: 21085570
Alzheimers Dement. 2015 Jun;11(6):658-71
pubmed: 25533204
JAMA. 2010 May 12;303(18):1832-40
pubmed: 20460622
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21365-70
pubmed: 19955433
Front Aging Neurosci. 2017 May 30;9:170
pubmed: 28611660
Metab Brain Dis. 2017 Oct;32(5):1595-1601
pubmed: 28608249
Nucl Recept Signal. 2009;7:e003
pubmed: 19381306
Nat Genet. 2011 May;43(5):436-41
pubmed: 21460841
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
PLoS One. 2011;6(7):e22545
pubmed: 21818335
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12292-12297
pubmed: 27791018
Nat Genet. 2011 May;43(5):429-35
pubmed: 21460840
Nat Genet. 2009 Oct;41(10):1088-93
pubmed: 19734902
J Affect Disord. 2013 Nov;151(2):702-8
pubmed: 24007783
J Neurochem. 2011 Oct;119(2):275-82
pubmed: 21848658
Diabetologia. 2015 Sep;58(9):1969-77
pubmed: 26109214
Nat Commun. 2017 Jul 31;8(1):162
pubmed: 28757615
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Sci Rep. 2017 Aug 17;7(1):8513
pubmed: 28819135
Cancer Cell. 2009 Apr 7;15(4):328-40
pubmed: 19345331
Nat Genet. 2017 Sep;49(9):1373-1384
pubmed: 28714976
Am J Clin Nutr. 2011 Apr;93(4):884S-90
pubmed: 21289221
Nat Commun. 2016 Feb 29;7:10753
pubmed: 26923714
Behav Brain Res. 2012 Jun 15;232(1):165-73
pubmed: 22510382
J Alzheimers Dis. 2015;44(3):827-38
pubmed: 25362032
Arch Neurol. 2009 Mar;66(3):352-61
pubmed: 19273754
Trends Endocrinol Metab. 2012 Sep;23(9):459-66
pubmed: 22817841
Hum Mol Genet. 2012 Aug 1;21(15):3461-73
pubmed: 22589246
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Trends Cancer. 2016 Oct;2(10):619-631
pubmed: 28607951
Arthritis Rheumatol. 2014 Dec;66(12):3413-23
pubmed: 25219468
Nat Genet. 2012 May 29;44(6):623-30
pubmed: 22641211
Nat Neurosci. 2015 Feb;18(2):199-209
pubmed: 25599223
Genet Epidemiol. 2018 Jun;42(4):366-377
pubmed: 29532500
Exp Cell Res. 2017 Apr 1;353(1):6-15
pubmed: 28238834
Front Endocrinol (Lausanne). 2018 May 18;9:255
pubmed: 29867779
Nucl Receptor Res. 2015;2:
pubmed: 26878025
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
N Engl J Med. 2013 Jan 10;368(2):117-27
pubmed: 23150934
Cell. 2006 Oct 6;127(1):59-69
pubmed: 17018277
Nature. 2007 May 24;447(7143):477-81
pubmed: 17476214
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19424-9
pubmed: 17151198
Am J Hum Genet. 2011 Mar 11;88(3):283-93
pubmed: 21397060
Cell. 2012 Aug 3;150(3):533-48
pubmed: 22863007
J Exp Med. 2013 Oct 21;210(11):2289-304
pubmed: 24081948
Am J Hum Genet. 2009 Jul;85(1):13-24
pubmed: 19539887
J Neurobiol. 2000 Feb 15;42(3):323-37
pubmed: 10645972
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81
pubmed: 8446617
PLoS One. 2014 Jun 12;9(6):e94661
pubmed: 24922517
Neurobiol Aging. 2011 Sep;32(9):1626-33
pubmed: 19923038
Alzheimers Res Ther. 2017 Apr 27;9(1):29
pubmed: 28446202
Arch Gen Psychiatry. 2006 Feb;63(2):168-74
pubmed: 16461860

Auteurs

Emily Baker (E)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

Rebecca Sims (R)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Ganna Leonenko (G)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Aura Frizzati (A)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Janet C Harwood (JC)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Detelina Grozeva (D)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Kevin Morgan (K)

Human Genetics, School of Life Sciences, Life Sciences Building A27, University Park, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.

Peter Passmore (P)

Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University, Belfast, United Kingdom.

Clive Holmes (C)

Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, United Kingdom.

John Powell (J)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, United Kingdom.
Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

Carol Brayne (C)

Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.

Michael Gill (M)

Mercer's Institute for Research on Ageing, St. James' Hospital, Dublin, Ireland.
James Hospital and Trinity College, Dublin, Ireland.

Simon Mead (S)

MRC Prion Unit at UCL, Institute of Prion Diseases, London, United Kingdom.

Paola Bossù (P)

Experimental Neuropsychobiology Laboratory, IRCCS Santa Lucia Foundation, Department of Clinical and Behavioral Neurology, Rome, Italy.

Gianfranco Spalletta (G)

Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.

Alison M Goate (AM)

Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St Louis, Missouri, United States of America.

Carlos Cruchaga (C)

Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America.
Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St Louis, Missouri, United States of America.

Wolfgang Maier (W)

German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.

Reinhard Heun (R)

Department of Psychiatry and Psychotherapy, University of Bonn, 53127, Bonn, Germany.

Frank Jessen (F)

German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Department of Psychiatry and Psychotherapy, University of Cologne, 50937 Cologne, Germany.

Oliver Peters (O)

Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.

Martin Dichgans (M)

Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, 80336, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Lutz FröLich (L)

Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.

Alfredo Ramirez (A)

Department of Psychiatry and Psychotherapy, University of Cologne, 50937 Cologne, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Lesley Jones (L)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

John Hardy (J)

Department of Molecular Neuroscience, UCL, Institute of Neurology, London, United Kingdom.

Dobril Ivanov (D)

UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

Matthew Hill (M)

UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

Peter Holmans (P)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Nicholas D Allen (ND)

UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

B Paul Morgan (BP)

UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

Sudha Seshadri (S)

Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America.

Gerard D Schellenberg (GD)

Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.

Philippe Amouyel (P)

Univ. Lille, Inserm, CHU Lille University Hospital, Institut Pasteur de Lille, LabEx DISTALZ-UMR1167 - RID-AGE - Risk factors and molecular determinants of aging-related, F-59000 Lille, France.

Julie Williams (J)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

Valentina Escott-Price (V)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH